CA2119253C — Medication vehicles made of solid lipid particles (solid lipid nanospheres-sln)
Assigned to Jagotec AG · Expires 1998-11-03 · 28y expired
What this patent protects
The invention relates to a drug carrier which comprises particles of lipid or li pid-like (lipoid) material or mixtures thereof which have a diameter of 10 nm to 10 .mu.m and whic h are solid at room temperature. On account of its solid core, the drug carrier allows a contro llab…
USPTO Abstract
The invention relates to a drug carrier which comprises particles of lipid or li pid-like (lipoid) material or mixtures thereof which have a diameter of 10 nm to 10 .mu.m and whic h are solid at room temperature. On account of its solid core, the drug carrier allows a contro llable liberation of active substances over a longer period of time and the incorporation of hydro philous medicinal agents into the solid core. Furthermore, the drug carrier makes a rela tively quick degrading possible at which no toxic by-products are produced.
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.